Publication:
First evidence of a pro-inflammatory response to severe infection with influenza virus H1N1

dc.contributor.authorFernández de Castro, Isabel
dc.contributor.authorGuzman-Fulgencio, Maria
dc.contributor.authorGarcia-Alvarez, Monica
dc.contributor.authorResino, Salvador
dc.contributor.funderInstituto de Salud Carlos III
dc.date.accessioned2019-05-21T08:54:55Z
dc.date.available2019-05-21T08:54:55Z
dc.date.issued2010
dc.description.abstractThe great majority of infections caused by the pandemic variant of the influenza virus (nvH1N1) are self-limited, but a small percentage of patients develop severe symptoms requiring hospitalization. Bermejo-Martin and colleagues have presented a pilot study describing the differences in the early immune response for patients both mildly and severely infected with nvH1N1. Patients who develop severe symptoms after nvH1N1 infection showed Th1 and Th17 'hypercytokinemia', compared to mildly infected patients and healthy controls. The mediators involved with the Th1 and Th17 profiles are known to be involved in antiviral, pro-inflammatory and autoimmune responses. This is the first work reporting the association of a pro-inflamatory immune response with a severe pandemic infection, although it is likely that more studies are needed to understand the detrimental or beneficial roles these cytokines play in the evolution of mild and severe nvH1N1 infection.es_ES
dc.description.peerreviewedes_ES
dc.description.sponsorshipThis work was supported by grants from Instituto de Salud Carlos III (PI08/0738; UIPY 1467/07) to SR. MG-F is supported by a grant of Instituto de Salud Carlos III (CM09/00031). MG-A is supported by a grant of Instituto de Salud Carlos III (CM08/00101).es_ES
dc.format.number1es_ES
dc.format.page115es_ES
dc.format.volume14es_ES
dc.identifier.citationCrit Care. 2010;14(1):115.es_ES
dc.identifier.doi10.1186/cc8846es_ES
dc.identifier.e-issn1466-609Xes_ES
dc.identifier.issn1364-8535es_ES
dc.identifier.journalCritical care (London, England)es_ES
dc.identifier.pubmedID20236480es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/7622
dc.language.isoenges_ES
dc.publisherBioMed Central (BMC)es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/PI08/0738es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/UIPY1467/07es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/CM09/00031es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/CM08/00101es_ES
dc.relation.publisherversionhttps://doi.org/10.1186/cc8846es_ES
dc.repisalud.centroISCIII::Centro Nacional de Microbiologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAtribución-NoComercial-CompartirIgual 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/*
dc.subject.meshCase-Control Studieses_ES
dc.subject.meshCytokineses_ES
dc.subject.meshHumanses_ES
dc.subject.meshInflammationes_ES
dc.subject.meshInfluenza A Virus, H1N1 Subtypees_ES
dc.subject.meshInfluenza, Humanes_ES
dc.titleFirst evidence of a pro-inflammatory response to severe infection with influenza virus H1N1es_ES
dc.typejournal articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublication946b9e38-f60e-4226-8735-78ceebc4111a
relation.isAuthorOfPublication7b71e6d9-e421-4483-8961-fa252b845788
relation.isAuthorOfPublication89b17350-14e3-4dfd-b797-6ee6ca5363b8
relation.isAuthorOfPublication.latestForDiscovery946b9e38-f60e-4226-8735-78ceebc4111a

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
FirstEvidenceOfA_2010.pdf
Size:
120.7 KB
Format:
Adobe Portable Document Format
Description: